Sanofi has filed their own inhalation device - oct 22, 2015

[peppy]

Nov 21, 2015 7:32:59 GMT -5 mnholdem said:

When you write, "All the Dreamboat does is..." that is the point. MannKind's inhaler does not enable adjustable dosing of, say, 1u - 30u of TI and DreamBoat does not communicate intake to a reader, for use in smart diabetes software packages.

Consumers may want those options.

I get the idea of new and improved inhaler for afrezza. I am not buying into that because isn't it the case the last time the inhaler was changed for new and improved, it caused more studies and a few years delay? Afrezza has adjustable dosing in the blister packs.

I think this is for a different medication. (I can be wrong.) Lakers has been putting up plenty of patents, including just recently a few sanofi new patents.

[mnholdem]

I agree that the Sanofi patent is most likely for another drug. I was simply making a point. Another very simple reason exists for Sanofi getting this patent, though. It could be a simple as filing a patent for an inhaler to block - or at least, discourage - competitors from doing the same.